ABSTRACT
Objective To investigate how to improve the survival rate,and to avoid the serious complications in fat grafting.Methods Under comprehensive design of facial filling area,the fat was harvested by concentration in mesh;under the micro autologous fat transplantation gun with blunt needle injection technique,the fat was filled into the face to achieve the effect of improving the facial contour and the rejuvenation.From June 2014 to July 2015,78 patients with facial contour and facial soft tissue relaxation depression were treatment by the technique.Results The follow-up of 2 months to 1 year showed that 64 patients had the soft,young,significantly enhanced facial contour;7 patients had second times grafts and the remaining were satisfied.7 patients gave up the second times grafts because the other reasons.The surgical complications such as facial nerve injury and infection and embolism were not seen.Conclusions This technique by comprehensive design and purification of autogenous fat granules achieves a better effect on facial rejuvenation with fewer complications.
ABSTRACT
Objective To study the effects of atractylenolide 3 on human platelet in vitro and explore the underlying mecha?nism. Methods The effects of atractylenolide 3 on human platelet aggregation induced by thrombus alkane analogues(U46619)was tested by turbidimetry in vitro. ATP secretion weas detected by luciferase detection,and the phosphorylation levels of Erk and Akt were detected by Western blotting. Results Atractylenolide 3 diminished U46619-induced human platelet aggregation in concentra?tion dependence. Compared with DMSO control group,the inhibitory rate were significant increased in each experiment group(P<0.01). Atractylenolide 3 inhibited adenosine triphosphate(ATP)secreted by human platclet in concentration dependence. Compared with the DMSO control group,the inhibitory rate were significant increased in each experiment group(P<0.01),and the levels of phospho-Akt(Ser473)and phospho-Erk1/2 were significant downregulated in the presence of atractylenolide 3 in each experiment group(P<0.01). Conclusion Atractylenolide 3 exhibits a concentration-dependent inhibitory effect on human platelet aggregation and secretion induced by U46619. Also,it regulated the MAPK and PI3K-Akt signaling pathways. These results show that atractyleno?lide 3 is an effective antiplatelet compound,may serve as new antithrombotic drugs.